Palmisiano, N.; Jeschke, G.; Wilde, L.; Alpdogan, O.; Carabasi, M.; Filicko-O’Hara, J.; Grosso, D.; Klumpp, T.; Martinez, U.; Wagner, J.;
et al. A Phase I Trial of Sirolimus with “7&3” Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia. Cancers 2023, 15, 5129.
https://doi.org/10.3390/cancers15215129
AMA Style
Palmisiano N, Jeschke G, Wilde L, Alpdogan O, Carabasi M, Filicko-O’Hara J, Grosso D, Klumpp T, Martinez U, Wagner J,
et al. A Phase I Trial of Sirolimus with “7&3” Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia. Cancers. 2023; 15(21):5129.
https://doi.org/10.3390/cancers15215129
Chicago/Turabian Style
Palmisiano, Neil, Grace Jeschke, Lindsay Wilde, Onder Alpdogan, Matthew Carabasi, Joanne Filicko-O’Hara, Dolores Grosso, Thomas Klumpp, Ubaldo Martinez, John Wagner,
and et al. 2023. "A Phase I Trial of Sirolimus with “7&3” Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia" Cancers 15, no. 21: 5129.
https://doi.org/10.3390/cancers15215129
APA Style
Palmisiano, N., Jeschke, G., Wilde, L., Alpdogan, O., Carabasi, M., Filicko-O’Hara, J., Grosso, D., Klumpp, T., Martinez, U., Wagner, J., Carroll, M. P., Perl, A., & Kasner, M.
(2023). A Phase I Trial of Sirolimus with “7&3” Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia. Cancers, 15(21), 5129.
https://doi.org/10.3390/cancers15215129
